ロード中...

Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?

The Insulin Degrading Enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer’s disease susceptibility gene though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.

保存先:
書誌詳細
主要な著者: Costes, Safia, Butler, Peter C.
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144405/
https://ncbi.nlm.nih.gov/pubmed/25100059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2014.07.016
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!